Kestra Advisory Services, LLC Eli Lilly & CO Transaction History

Kestra Advisory Services, LLC

$17.3 Billion
Q3 2024

A detailed history of Kestra Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 86,553 shares of LLY stock, worth $65.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

86,553

Previous 90,521 4.38%

Holding current value

$65.2 Million

Previous $82 Million 6.44%

% of portfolio

0.44%

Previous 0.47%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $3.06 Million - $3.81 Million	-3,968 Reduced 4.38%	86,553 $76.7 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $10.8 Million - $13.5 Million	14,841 Added 19.61%	90,521 $82 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $6.13 Million - $8.21 Million	10,359 Added 15.86%	75,680 $58.9 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $3.33 Million - $3.93 Million	6,343 Added 10.75%	65,321 $38.1 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $665,525 - $917,528	1,531 Added 2.67%	58,978 $31.7 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $119,953 - $160,391	342 Added 0.6%	57,447 $26.9 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $5.13 Million - $6.03 Million	-16,527 Reduced 22.45%	57,105 $19.6 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $2.5 Million - $2.92 Million	7,786 Added 11.82%	73,632 $26.9 Million
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $3.01 Million - $3.43 Million	-10,150 Reduced 13.36%	65,846 $21.3 Billion
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $6.71 Million - $7.87 Million	24,058 Added 46.32%	75,996 $24.6 Million
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $911,301 - $1.13 Million	3,883 Added 8.08%	51,938 $14.9 Million
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $655,887 - $813,959	2,917 Added 6.46%	48,055 $13.3 Million
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $316,444 - $389,429	-1,428 Reduced 3.07%	45,138 $10.4 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $269,561 - $348,675	1,493 Added 3.31%	46,566 $10.7 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $2.88 Million - $3.73 Million	-17,525 Reduced 28.0%	45,073 $8.42 Million
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $2.41 Million - $3.19 Million	18,467 Added 41.85%	62,598 $10.5 Billion
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $6.45 Million - $7.46 Million	44,131 New	44,131 $6.53 Billion

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Eli Lilly & CO Transaction History